Targeting ferroptosis to halt MASLD and MASH
Trends in Endocrinology & Metabolism · 2026-08 · 37 (8) · 736-746
DOI: 10.1016/j.tem.2026.01.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-08. Verfasst von Fudi Wang. Beteiligte Einrichtung: The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Han…. Hauptthemen laut MEDLINE: Ferroptosis, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou, 310058, China; Global Innovation Institute of Element Science (…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, F. (2026). Targeting ferroptosis to halt MASLD and MASH. Trends in Endocrinology & Metabolism, 37(8), 736-746. https://doi.org/10.1016/j.tem.2026.01.007
Vancouver
Wang F. Targeting ferroptosis to halt MASLD and MASH. Trends in Endocrinology & Metabolism. 2026;37(8):736-746. doi:10.1016/j.tem.2026.01.007
BibTeX
@article{Wang2026,
author = {Wang, Fudi},
title = {Targeting ferroptosis to halt MASLD and MASH},
journal = {Trends in Endocrinology & Metabolism},
year = {2026},
volume = {37},
number = {8},
pages = {736--746},
doi = {10.1016/j.tem.2026.01.007}
}
EUVIMED